Christina Applegate, who was diagnosed with multiple sclerosis in 2021, opened up on the podcast "Conan O'Brien Needs a Friend" about how difficult it is to live with MS. She said people imply she ...

For Pree, diagnosed with multiple sclerosis at 19, finishing college was a challenge. Still, amidst it all, she decided to open up about her journey by sharing her first video on YouTube.

Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis — and a new study suggests that supplementing it in high doses could help reduce symptoms.

Multiple sclerosis symptoms in females may be different or worse than in men. Females may be more likely to experience vision changes, fatigue, and cognitive problems.

How to Use the Kesimpta Sensoready Pen Do not remove the cap until you are ready to inject the dose. Below is a list of things you will need to get ready for the injection. These items are not ...

LEHI — A new clinic for patients with multiple sclerosis is officially open in Utah County. Rocky Mountain MS Clinic opened a new location at 3300 N. 1200 West in Lehi on Monday.

Multiple sclerosis (MS) is a demyelinating neurological condition. “Demyelinating” means the loss of the protective sheath around nerves in your central nervous system.

According to a 2022 study, the estimated total economic burden of multiple sclerosis in the U.S. was $85.4 billion in 2019, with a direct medical cost of $63.3 billion; indirect and nonmedical ...

A generation ago, most people with multiple sclerosis could expect to rely on walkers and wheelchairs or be limited to their bed within 15 years of diagnosis. Today, UC San Francisco’s discoveries are ...

Christina Applegate is continuing to speak candidly about her battle with multiple sclerosis. The "Dead to Me" star, 53, became emotional discussing her health in an episode of " Conan O'Brien ...

A Sanofi experimental drug for multiple sclerosis delayed disability progression in a late-stage trial, but failed to reduce episodes of new or worsening symptoms compared to an existing treatment ...

The mean (±SD) time since the diagnosis of secondary progressive multiple sclerosis was 7.9±7.3 years in the tolebrutinib group and 8.4±7.8 years in the placebo group, and the time since the ...